Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer
1644.0000 -12.00 (-0.72%)
NSE Sep 22, 2025 15:31 PM
Volume: 1.8M
 

logo
Sun Pharmaceutical Industries Ltd.
10 Mar 2025
1644.00
-0.72%
buy
by BOB Capital Markets Ltd.
Target: 2086 | Upside : 26.9%
BOB Capital Markets Ltd.
SUNP to acquire Checkpoint Therapeutic for US$ 4.10 a share, at ~66% premium to its last closing price. Deal valued at US$ 355mn
 
Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
More from Sun Pharmaceutical Industries Ltd.
Recommended
IPO market heats up: 29 new offerings and 8 listings this week
| 22 Sep 2025, 05:34PM
Market closes lower, Brigade Enterprises gets Rs 126 cr investment from Manipal Group
Trendlyne Marketwatch | 22 Sep 2025, 03:58PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022